Millrace Asset Group’s Apyx Medical APYX Stock Holding History

Millrace Asset Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-126,024	Closed	-$823K	–	62
2022 Q1	$823K	Sell	126,024 -22,899	-15%	-$226K	0.6%	64
2021 Q4	$1.91M	Sell	148,923 -61,946	-29%	-$867K	1.11%	39
2021 Q3	$2.92M	Buy	210,869 +13,292	+7%	+$140K	1.83%	16
2021 Q2	$2.04M	Buy	197,577 +20,990	+12%	+$208K	1.06%	49
2021 Q1	$1.71M	Buy	176,587 +10,051	+6%	+$101K	0.92%	58
2020 Q4	$1.2M	Buy	166,536 +112,594	+209%	+$746K	0.83%	60
2020 Q3	$254K	Buy	+53,942	New	+$267K	0.21%	76
2020 Q2	–	Sell	-59,364	Closed	-$213K	–	74
2020 Q1	$213K	Sell	59,364 -249,499	-81%	-$1.67M	0.32%	60
2019 Q4	$2.61M	Buy	308,863 +23,850	+8%	+$172K	2.84%	2
2019 Q3	$1.93M	Sell	285,013 -15,000	-5%	-$106K	2.26%	9
2019 Q2	$2.02M	Sell	300,013 -155,300	-34%	-$844K	2.08%	13
2019 Q1	$2.87M	Sell	455,313 -124,301	-21%	-$962K	2.42%	5
2018 Q4	$3.75M	Sell	579,614 -37,354	-6%	-$226K	3.44%	2
2018 Q3	$4.38M	Sell	616,968 -111,185	-15%	-$618K	3.41%	1
2018 Q2	$3.17M	Buy	728,153 +96,404	+15%	+$356K	2.42%	6
2018 Q1	$1.88M	Buy	631,749 +52,349	+9%	+$135K	1.82%	23
2017 Q4	$1.51M	Buy	579,400 +264,400	+84%	+$825K	1.45%	36
2017 Q3	$1.06M	Buy	+315,000	New	+$813K	1%	52
2015 Q4	–	Sell	-146,498	Closed	-$286K	–	54
2015 Q3	$286K	Sell	146,498 -345,240	-70%	-$791K	0.31%	53
2015 Q2	$1.37M	Buy	+491,738	New	+$1.35M	1.43%	35

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Millrace Asset Group's APYX Position: Q2 2022 in Review

Millrace Asset Group sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 126,024 shares — an estimated $823K sold.

Millrace Asset Group first reported a position in APYX in Q2 2015 and held it in 20 quarters. The position peaked at $4.38M in Q3 2018. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Millrace Asset Group reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Millrace Asset Group sold 126,024 Apyx Medical shares in Q2 2022, an estimated $823K.
Millrace Asset Group first reported a position in Apyx Medical in Q2 2015 and held it in 20 quarters.
Millrace Asset Group's Apyx Medical position peaked at $4.38M in Q3 2018.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Millrace Asset Group's 13F filing for Q2 2022, filed 28 Jul 2022.